Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for about US$10b, reigniting takeover speculation across the obesity drug sector. Followin...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for about US$10… [+6208 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account